Bromide

Bromide

SCHEMBL1316441

CCCCCCCCCCCCOCC(COCCCCCCCCCCCC)(COCC[N+](CC)(CC)CC)COCC[N+](CC)(CC)CC.[Br-].[Br-]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 4/20 0.50
CES1 P23141 1/20 0.43
PRKD3 O94806 1/20 0.42
PRKCG P05129 1/20 0.42
PRKCB P05771 1/20 0.42
PRKCA P17252 1/20 0.42
PRKCH P24723 1/20 0.42
PRKCI P41743 1/20 0.42
PRKCE Q02156 1/20 0.42
PRKCQ Q04759 1/20 0.42
PRKCZ Q05513 1/20 0.42
PRKCD Q05655 1/20 0.42
PRKD1 Q15139 1/20 0.42
ALDH1A1 P00352 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
ALOX12 P18054 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1319377 1.00 DNM1 (0.50) DNM1CES1PRKD3PRKCGPRKCB
Bromide SCHEMBL1320796 1.00 DNM1 (0.50) DNM1CES1PRKD3PRKCGPRKCB
SCHEMBL12120076 0.88 DNM1 (0.42) DNM1CES1PRKD3PRKCGPRKCB
SCHEMBL12120063 0.88 DNM1 (0.42) DNM1CES1PRKD3PRKCGPRKCB
SCHEMBL12120069 0.88 DNM1 (0.42) DNM1CES1PRKD3PRKCGPRKCB
SCHEMBL12120053 0.87 DNM1 (0.41) DNM1CES1PRKD3PRKCGPRKCB
SCHEMBL24465404 0.85 DNM1 (0.58) DNM1PRKD3PRKCGPRKCBPRKCA
Bromide SCHEMBL1318015 0.84 DNM1 (0.52) DNM1CES1PRKD3PRKCGPRKCB
SCHEMBL4875783 0.82 CES1 (0.57) CES1ALDH1A1TSHRHTTMEN1
SCHEMBL11149666 0.82 CES1 (0.57) CES1ALDH1A1TSHRHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110269652-A1 GEMINI SURFACTANTS ST. FRANCIS XAVIER UNIVERSITY (CA) 2011-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269652-A1 GEMINI SURFACTANTS SGMS1, DEGS1, GMNN DNM1 2074/4885CES1 103/4885PRKD3 3017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.